Bromide

Bromide

SCHEMBL6376002

Br.Cc1ncc(Cl)n1CCN

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.34
CA1 P00915 4/20 0.33
CA2 P00918 4/20 0.33
CA9 Q16790 4/20 0.33
LMNA P02545 2/20 0.33
THRB P10828 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
GAA P10253 1/20 0.33
BRD4 O60885 1/20 0.31
CA12 O43570 3/20 0.31
GLA P06280 1/20 0.31
CYP2C19 P33261 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.30
CHEK1 O14757 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6182712 0.78 LMNA (0.36) ALDH1A1CA1CA2CA9LMNA
SCHEMBL13754409 0.76 LMNA (0.35) ALDH1A1CA1CA2CA9LMNA
SCHEMBL1184137 0.75
Bromide SCHEMBL28927808 0.70 PRMT5 (0.31) CA1CA2CA9CYP2C19
SCHEMBL1031729 0.68 LMNA (0.71) ALDH1A1CA1CA2CA9LMNA
SCHEMBL451876 0.68
Hydrochloric Acid SCHEMBL12005237 0.67 LMNA (0.69) ALDH1A1CA1CA2CA9LMNA
Hydrochloric Acid SCHEMBL12004704 0.67 LMNA (0.69) ALDH1A1CA1CA2CA9LMNA
Hydrochloric Acid SCHEMBL7585345 0.67 ALDH1A1 (0.59) ALDH1A1LMNAGAABRD4CYP2C19
Bromide SCHEMBL6182780 0.67 ALDH1A1 (0.49) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050153964-A1 Pyrimidone compounds which are inhibitors of the enzyme Lp-PLA2; use in treating atheroscelerosis GLAXO GROUP LIMITED (GB) 2005-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050153964-A1 Pyrimidone compounds which are inhibitors of the enzyme Lp-PLA2; use in treating atheroscelerosis LYPLAL1, PLA2G12A, ENPP2 ALDH1A1 1095/4885CA1 4680/4885CA2 4032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.